Genetic Variation in LPAL2 , LPA , and PLG Predicts Plasma Lipoprotein(a) Level and Carotid Artery Disease Risk | Zendy

James Ronald | Zendy; Ramakrishnan Rajagopalan | Zendy; Felecia Cerrato | Zendy; Alex S. Nord | Zendy; Thomas S. Hatsukami | Zendy; Ted R. Kohler | Zendy; Santica M. Marcovina | Zendy; Patrick J. Heagerty | Zendy; Gail P. Jarvik | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Genetic Variation in LPAL2 , LPA , and PLG Predicts Plasma Lipoprotein(a) Level and Carotid Artery Disease Risk

Author(s) -

James Ronald,

Ramakrishnan Rajagopalan,

Felecia Cerrato,

Alex S. Nord,

Thomas S. Hatsukami,

Ted R. Kohler,

Santica M. Marcovina,

Patrick J. Heagerty,

Gail P. Jarvik

Publication year - 2010

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.110.591230

Subject(s) - medicine , lipoprotein(a) , disease , cardiology , genetic variation , carotid arteries , variation (astronomy) , carotid artery disease , stroke (engine) , vascular disease , lipoprotein , cholesterol , carotid endarterectomy , population , environmental health , mechanical engineering , physics , astrophysics , engineering

lipoprotein(a) [Lp(a)] level is an established risk factor for coronary artery disease and has been implicated in carotid artery disease (CAAD). The relationship between genetic variation in the LPA gene region and CAAD risk remains unknown.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research